Lactulose Oral Solution Suppliers & Bulk Manufacturers
Available Forms: Oral solution
Available Strengths: 10 g/15 mL
Reference Brands: Enulose(US)
Category:
Gastrointestinal Drugs
Lactulose oral solution is an osmotic laxative that draws water into the colon, softening stool and promoting bowel movements. It reduces ammonia levels in liver disease, supports detoxification, and relieves constipation. Benefits include improved bowel regularity, reduced hepatic encephalopathy risk, and enhanced digestive and liver health.
Lactulose oral solution is available in Oral solution
and strengths such as 10 g/15 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lactulose oral solution is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lactulose oral solution can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lactulose oral solution, marketed as Duphalac and Enulose, is approved in the US by the FDA and in the EU via EMA for constipation and hepatic encephalopathy. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data, while EMA ensures compliance with regional safety and manufacturing requirements. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports timely approval, safe use, and worldwide availability of lactulose oral solutions, enhancing gastrointestinal and liver health management across diverse patient populations globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing